Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

This publication has 10 references indexed in Scilit:

• X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis
  Blood, 2006
• Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
  Leukemia, 2005
• Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study
  The Lancet, 2005
• Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
  Leukemia, 2005
• On the molecular origins of the chronic myeloproliferative disorders: it all makes sense
  Blood, 2005
• A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications
  Blood, 1999
• X-Chromosome inactivation in healthy females: incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms
  Clinical Chemistry, 1998
• Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and Platelets
  Blood, 1997
• Use of Restriction Fragment Length Polymorphisms to Determine the Clonal Origin of Human Tumors
  Science, 1985